KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Accumulated Expenses (2016 - 2022)

Gilead Sciences filings provide 14 years of Accumulated Expenses readings, the most recent being $3.7 billion for Q3 2022.

  • On a quarterly basis, Accumulated Expenses rose 9.09% to $3.7 billion in Q3 2022 year-over-year; TTM through Sep 2022 was $3.7 billion, a 9.09% increase, with the full-year FY2021 number at $3.2 billion, down 6.24% from a year prior.
  • Accumulated Expenses hit $3.7 billion in Q3 2022 for Gilead Sciences, down from $4.1 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $4.1 billion in Q3 2020 to a low of $2.3 billion in Q3 2018.
  • Median Accumulated Expenses over the past 5 years was $3.3 billion (2020), compared with a mean of $3.3 billion.
  • Biggest five-year swings in Accumulated Expenses: tumbled 33.27% in 2018 and later surged 64.62% in 2019.
  • Gilead Sciences' Accumulated Expenses stood at $3.1 billion in 2018, then fell by 2.07% to $3.1 billion in 2019, then grew by 12.56% to $3.5 billion in 2020, then fell by 6.24% to $3.2 billion in 2021, then grew by 13.26% to $3.7 billion in 2022.
  • The last three reported values for Accumulated Expenses were $3.7 billion (Q3 2022), $4.1 billion (Q2 2022), and $3.5 billion (Q1 2022) per Business Quant data.